RTI Surgical

Rank: 91

2016 Rank100 Employees1,140 Revenue:$272,865,000 R&D Spend:$16,090,000 Fiscal year ending:12-31-16 Click here to see all 100

RTI is a global surgical implant company providing surgeons and patients with a broad portfolio of biologic, metal and synthetic implants.

RTI Surgical® Announces Launch of Release® Laminoplasty Fixation System. RTI Surgical® Announces Launch of Streamline® TL Spinal Fixation System – Deformity Instrumentation. RTI Surgical® Announces Limited Launch and First Implantation of Unison™-C Anterior Cervical Fixation System. RTI Surgical® Announces Agreement with Oxford Performance Materials. nanOss® 3D Advanced Bone Graft Substitute Receives 2015 Becker’s Healthcare Award. RTI Surgical™ Announces Agreement With Novation.

Key Personnel: Camille Farhat, president & CEO; Robert Jordheim, EVP & CFO; Kevin Brandt, EVP, chief commercial officer; John Varela, EVP, global operations; Paul Montague, VP, HR; Roger Rose, EVP, Pres, RTI donor services; Enrico Sangiorgio, VP & GM, international markets; Keith Koford, VP, legal, regulatory & clinical affairs; Bryan Martin, VP, global QA; Dr. Lennox Archibald, medical director; Thomas Rose, secretary;

http://www.rtix.com/en_us/